Showing results (1-10 of 199) with videos related to
Sort By:
Pageof 20
Antiviral Chemistry & Chemotherapy|April 13, 2004
Challenges for the development of ribonucleoside analogues as inducers of error catastropheJason D Graci, Craig E CameronFuture Virology|September 4, 2009
Therapeutically targeting RNA viruses via lethal mutagenesisJason D Graci, Craig E CameronVirology|July 20, 2002
Quasispecies, error catastrophe, and the antiviral activity of ribavirinJason D Graci, Craig E CameronReviews in Medical Virology|November 16, 2005
Mechanisms of action of ribavirin against distinct virusesJason D Graci, Craig E CameronJournal of Virology|December 23, 2011
Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesisJason D Graci, Nina F Gnädig, Jessica E Galarraga, et al.Journal of Medicinal Chemistry|December 11, 2007
Effects of introduction of hydrophobic group on ribavirin base on mutation induction and anti-RNA viral activityKei Moriyama, Tetsuya Suzuki, Kazuo Negishi, et al.Journal of Medicinal Chemistry|October 13, 2006
Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerasesDaniel A Harki, Jason D Graci, Jessica E Galarraga, et al.Biochemistry|July 18, 2002
Synthesis and antiviral evaluation of a mutagenic and non-hydrogen bonding ribonucleoside analogue: 1-beta-D-Ribofuranosyl-3-nitropyrroleDaniel A Harki, Jason D Graci, Victoria S Korneeva, et al.The Journal of Biological Chemistry|September 13, 2014
RNA virus population diversity, an optimum for maximal fitness and virulenceVictoria K Korboukh, Cheri A Lee, Ashley Acevedo, et al.Journal of Virology|August 10, 2007
Lethal mutagenesis of poliovirus mediated by a mutagenic pyrimidine analogueJason D Graci, Daniel A Harki, Victoria S Korneeva, et al.Pageof 20